leadf
logo-loader
TSX-V:ACST NASDAQ:ACST

Acasti Pharma Inc

Receive alerts
Market:
TSX-V
Market Cap:
$117.81 m
Price
2.66 CAD
Change
-8.90%
52 weeks high
12.40
52 weeks low
1.84

In brief

Acasti is a biopharmaceutical innovator focused on the research, development and commercialization of prescription drugs using omega-3 fatty acids derived from krill oil. Omega-3 fatty acids have extensive clinical evidence of safety and efficacy in lowering triglycerides in patients with hypertriglyceridemia. Market research commissioned by Acasti suggests there is an important market need for an effective, safe and well-absorbing omega-3 therapeutic with a positive impact on the major lipids associated with cardiovascular disease risk. Since August 2008, Acasti is focused on addressing this important unmet market need.

Snapshot

In September 2020, Acasti engaged Oppenheimer & Company Inc to act as its financial advisor to assist in the review aimed at enhancing shareholder value